Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns

Documenti analoghi

• A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
  di: Ajmeera A. Azeez, et al.
  Pubblicazione: (2025)
• Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia
  di: Oscar Correa-Jimenez
  Pubblicazione: (2021)
• The fate of thiopurine metabolites after switching to low‐dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis
  di: Ahmed B. Bayoumy, et al.
  Pubblicazione: (2025)
• Invisible variables: how erythrocytes and leukocytes define platelet‐rich plasma efficacy in veterinary medicine
  di: K Sharun, et al.
  Pubblicazione: (2025)
• Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
  di: Abhinav Vasudevan, et al.
  Pubblicazione: (2024)